← SynDRA
EXATECAN
SynDRA canonical compound SYN0025673 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TOP1 |
| Mechanism of action | topoisomerase inhibitor |
All known targets
Mechanisms of action (all sources)
- TOP1 INHIBITOR
- DNA topoisomerase I inhibitor
- topoisomerase inhibitor
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase I Inhibitors
- Topoisomerase Inhibitors
Cross-references
Synonyms
- DX 8951
- DX-8951a
- DX-8951f
- exatecan mesylate
- exatecan hydrochloride
- DX-8951
- Exatecan mesylate
- UM-1
- UM-2
- exatecan.mesylate
- Exatecan [INN]
- OC71PP0F89
- Dx 8951
- (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione
- UNII-OC71PP0F89
- exatecan-mesylate
- (1s,9s)-1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10h,13h-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione
- EXATECAN [MI]
- EXATECAN [WHO-DD]
- SCHEMBL2512959
- CHEMBL1614650
- DTXSID60169061
- CHEBI:135709
- EX-A2683
- ZINC3800855
- NSC829066
- AKOS005146469
- AT33978
- BCP9000674
- DB12185
- NSC-829066
- 10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S,9S)-
- 10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S-trans)-
- AC-32495
- BP-27996
- HY-13631
- DB-064817
- DX8951;DX 8951;DX-8951
Look up EXATECAN in the interactive SynDRA portal →